- 5 October 2015 The treatment of rare diseases requires extreme refinement (La Recherche)
- 28 July 2015 Genethon:a gene therapy drug being tested in the US
- 15 May 2015 ASGCT 18th Annual Meeting 2015: Ana Buj Bello receives the Outstanding New Investigator Award
Created in 1990 by AFM-TELETHON, Genethon is fully dedicated to the design, development and production of gene therapy treatments for rare diseases. Its objective is to provide these innovative treatments to patients affected with rare disorders.
Genethon is developing therapies for rare neuromuscular diseases, immune system or blood disorders, eye disorders, liver and nervous system diseases.